Literature DB >> 10442467

Predictors of cancer mortality in elderly subjects.

A Mazza1, E Casiglia, R Scarpa, V Tikhonoff, A Pizziol, E Sica, A C Pessina.   

Abstract

Cancer mortality was analysed in 3282 elderly subjects aged > or =65 years from 2 cohorts of general population having different life-style patterns. They took part in the CASTEL (CArdiovascular STudy in the ELderly), a 12-year lasting prospective Italian study. The aim of the present analysis was to identify the items able to influence cancer mortality. A biochemical profile and a questionnaire on lifestyle were collected. Continuous items were averaged and compared with analysis of variance, frequencies with the Pearson's chi2 test. Mortality was recorded yearly for 12 years from the Registrar's Office and causes of death double-checked by consulting medical case sheets and family doctors' files. The influence of items on mortality was evaluated with the Cox multivariate analysis. Relative risk (RR) of each item was adjusted for confounders. Age, gender, tobacco smoking, the presence of respiratory symptoms, low body mass index in males, serum alanine transaminase (ALT) and alkaline phosphatase (ALP), as well as the town of residence, were powerful predictors of cancer mortality. In the entire population, 12-year overall mortality was 49.4%, cardiovascular 22.8%, and neoplastic 11%; the latter was higher in males than in females (15.7% vs. 7.9%, p < 0.00001). In subjects with respiratory symptoms neoplastic mortality was 11.6% (RR: 1.47) vs. 9.7% in those without symptoms (p < 0.01). Subjects with very low cholesterol (< or = 178 mg/dl), those with high uric acid (> or =8.7 mg/ dl) and males with low body mass index (< or =22.7 kg/ m2) has an increased risk of cancer mortality. RR of cancer mortality increased with increasing ALT or ALP. It was approximately 1 in those having ALT and ALP between 9 and 41.2 U/I, 1.41 in those exceeding this latter level and < 1 in those below 9 U/I. RR of ALP had a similar trend, the best protective cut-off value being < 106 and the worst one > 177 U/I. When both serum enzymes were simultaneously raised, RR of cancer mortality increased to 2.84.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442467     DOI: 10.1023/a:1007543725207

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  41 in total

Review 1.  The change in tumor aggressiveness with age: lessons from experimental animals.

Authors:  P R Kaesberg; W B Ershler
Journal:  Semin Oncol       Date:  1989-02       Impact factor: 4.929

2.  Body mass index and lung cancer risk.

Authors:  G C Kabat; E L Wynder
Journal:  Am J Epidemiol       Date:  1992-04-01       Impact factor: 4.897

3.  Activity and mortality among aged persons over an eight-year period.

Authors:  D J Lee; K S Markides
Journal:  J Gerontol       Date:  1990-01

4.  The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer.

Authors:  G C Kabat; C J Chang; E L Wynder
Journal:  Int J Epidemiol       Date:  1994-12       Impact factor: 7.196

5.  Serum uric acid unrelated to cancer incidence in humans.

Authors:  R A Hiatt; B H Fireman
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

6.  Noncancer deaths in white adult cancer patients.

Authors:  B W Brown; C Brauner; M C Minnotte
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

Review 7.  Gerontology as oncology. Research on aging as the key to the understanding of cancer.

Authors:  R A Miller
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

8.  Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.

Authors:  G Bacci; P Picci; S Ferrari; M Orlandi; P Ruggieri; R Casadei; A Ferraro; R Biagini; A Battistini
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Dyspnea in terminally ill cancer patients.

Authors:  D B Reuben; V Mor
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

Review 10.  The 1993 ISOBM Abbott Award Lecture. Isozymes, tumor markers and oncodevelopmental biology.

Authors:  W H Fishman
Journal:  Tumour Biol       Date:  1995
View more
  3 in total

1.  The association between serum liver enzymes and cancer mortality.

Authors:  Somaya Albhaisi; Rehan Qayyum
Journal:  Clin Exp Med       Date:  2021-07-08       Impact factor: 3.984

Review 2.  Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Shushan Yan; Pengjun Zhang; Wei Xu; Yuqing Liu; Bin Wang; Tao Jiang; Changjiang Hua; Xuan Wang; Donghua Xu; Beicheng Sun
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

Review 3.  Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects.

Authors:  Weijie Wang; Donghua Xu; Bin Wang; Shushan Yan; Xiaochen Wang; Yin Yin; Xuehao Wang; Beicheng Sun; Xiaoyang Sun
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.